UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 493

Sortiert nach

1005

Experimental hematology, 2023, Vol.124, p.S22

Sadelain, Michel

2023

Link zum Volltext

Verfügbarkeit prüfen

1055. High Levels of Human Factor IX Expression in Hemophilia B Mice after Adult Stem Cell-Based Gene Therapy Combined with Non-Myeloablative Conditioning

Molecular therapy, 2006-05, Vol.13 (S1), p.S404-S404

2006

Link zum Volltext

Verfügbarkeit prüfen

[131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity

European journal of nuclear medicine and molecular imaging, 2006-09, Vol.33 (9), p.988-997

2006

Link zum Volltext

Verfügbarkeit prüfen

132 HLA-independent T cell receptors effectively target low abundance antigens

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A142-A142

2021

Link zum Volltext

Verfügbarkeit prüfen

137 Genomics of multiple myeloma influences the expression of CAR T-cell targets

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A150-A150

2020

Link zum Volltext

Verfügbarkeit prüfen

IL-15 Augments in-Vitro Expansion and Functional Activity of Antigen-Specific Effector Memory T-Cells (TEM) While Co-Expression of IL-15 and IL-15 Rα on Antigen Presenting Cells Also Promotes Expansion of Central Memory T-Cells (TCM)

Blood, 2008-11, Vol.112 (11), p.3541-3541

2008

Link zum Volltext

Verfügbarkeit prüfen

2017 - Engineering Converted Autologous Hematopoietic Stem Cells From Vascular Endothelial for Treatment of Hemoglobinopathies

Experimental hematology, 2018-08, Vol.64, p.S46-S46

2018

Link zum Volltext

Verfügbarkeit prüfen

206 - Synergism between CAR T Cells and a Personalized Tumor Vaccine in Hematological Malignances

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S168-S169

2022

Link zum Volltext

Verfügbarkeit prüfen

207. Optimal Activation of Both CD28 and 4-1BB in CAR-Targeted T Cells Results in Enhanced Tumor Eradication

Molecular therapy, 2015-05, Vol.23, p.S82-S82

2015

Link zum Volltext

Verfügbarkeit prüfen

225. Activation Signals from CD19-CAR Permit NFAT-Controlled Inducible Expression of Transgenes in PBMCs

Molecular therapy, 2015-05, Vol.23, p.S89-S89

2015

Link zum Volltext

Verfügbarkeit prüfen

269. Integrated CD28 and 4-1BB Signals Strongly Potentiate CD8+ T Cell Mediated radication of Metastatic Prostate Cancer

Molecular therapy, 2006-05, Vol.13 (S1), p.S103-S103

2006

Link zum Volltext

Verfügbarkeit prüfen

274. One-Step Generation of Universal CAR T Cells

Molecular therapy, 2016-05, Vol.24, p.S109-S109

2016

Link zum Volltext

Verfügbarkeit prüfen

3152 – GENOMICS OF MULTIPLE MYELOMA DICTATES THE EXPRESSION OF CAR T-CELL TARGETS

Experimental hematology, 2020-08, Vol.88, p.S85-S85

2020

Link zum Volltext

Verfügbarkeit prüfen

317 BLOCKADE OF TGFβ ENHANCES EFFICACY OF GENETICALLY MODIFIED HUMAN T CELLS TARGETED AGAINST PROSTATE SPECIFIC MEMBRANE ANTIGEN

The Journal of urology, 2012-04, Vol.187 (4), p.e128-e129

2012

Link zum Volltext

Verfügbarkeit prüfen

317 BLOCKADE OF TGFβ ENHANCES EFFICACY OF GENETICALLY MODIFIED HUMAN T CELLS TARGETED AGAINST PROSTATE SPECIFIC MEMBRANE ANTIGEN

The Journal of urology, 2012, Vol.187 (4), p.e128-e129

2012

Link zum Volltext

Verfügbarkeit prüfen

343. Repair of the Sickle-Cell Disease Mutation in Human Stem Cells Using CRISPR/Cas9 and Single-Stranded Oligodeoxynucleotides

Molecular therapy, 2015-05, Vol.23, p.S137-S137

2015

Link zum Volltext

Verfügbarkeit prüfen

4-1BBL costimulation enables CD4 T cells expressing a CD28/zeta chimeric antigen receptor to eliminate aggressive leukemia. (P4338)

The Journal of immunology (1950), 2013-05, Vol.190 (1_Supplement), p.177-177.2

2013

Link zum Volltext

Verfügbarkeit prüfen

459. Evaluation of Miltenyi ExpAct and TransAct CD3/28 Beads for CAR-T Cell Manufacturing

Molecular therapy, 2016-05, Vol.24, p.S182-S182

2016

Link zum Volltext

Verfügbarkeit prüfen

475. Phase I Clinical Trial of Autologous CD19-Targeted 19-28z CAR T Cells in Adult Patients With Relapsed or Refractory B-ALL

Molecular therapy, 2015-05, Vol.23, p.S188-S189

2015

Link zum Volltext

Verfügbarkeit prüfen

512 Targeting HLA-E positive cancers with a novel NKG2A/C switch receptor

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A578-A578

2023

Link zum Volltext

Verfügbarkeit prüfen

608: Neutral Endopeptidase Targeted to Prostate Cancer Cells Via Fusion with an Anti-Prostate Specific Membrane Antigen Monoclonal Antffiody

The Journal of urology, 2004-04, Vol.171 (4), p.161-162

2004

Link zum Volltext

Verfügbarkeit prüfen

652. Analysis of the Genomic Stability of Herpes Simplex Virus Thymidine Kinase Variants in Retrovirally Transduced Lymphocytes

Molecular therapy, 2004-05, Vol.9 (S1), p.S246-S247

2004

Link zum Volltext

Verfügbarkeit prüfen

IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell–mediated rejection of systemic lymphoma in immunodeficient mice

Blood, 2010-04, Vol.115 (17), p.3508-3519

2010

Link zum Volltext

Verfügbarkeit prüfen

763. Multimodality Imaging of Genetically Modified Lymphocytes In Vivo

Molecular therapy, 2006-05, Vol.13 (S1), p.S295-S295

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1150: CD70 HIT T cells overcome tumor antigen heterogeneity in renal cell carcinoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1150-1150

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 493

Suche als RSS-Feed

Aktive Filter

PublikationsformReviews

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(463)
Mit Volltextzugriff
(417)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(247)
Life Sciences & Biomedicine
(224)
Humans
(210)
Animals
(147)
Mice
(111)
Biological And Medical Sciences
(66)
Medicine, Research & Experimental
(65)
Research & Experimental Medicine
(65)
Gene Therapy
(64)
Oncology
(63)
T-Lymphocytes - Immunology
(63)
Lymphocytes
(59)
Male
(50)
Tumors
(50)
Immunotherapy
(48)
Medical Sciences
(48)
Hematology
(46)
Antigens
(45)
Biotechnology & Applied Microbiology
(45)
Immunology
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(96)
Molecular Therapy
(35)
Cancer Research
(29)
Nature Biotechnology
(21)
The Journal Of Immunology
(20)
Journal Of Clinical Oncology
(16)
Nature Medicine
(14)
Nature
(10)
Proceedings Of The National Academy Of Sciences - Pnas
(9)
Biology Of Blood And Marrow Transplantation
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

1005

1055. High Levels of Human Factor IX Expression in Hemophilia B Mice after Adult Stem Cell-Based Gene Therapy Combined with Non-Myeloablative Conditioning

[131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity

132 HLA-independent T cell receptors effectively target low abundance antigens

137 Genomics of multiple myeloma influences the expression of CAR T-cell targets

IL-15 Augments in-Vitro Expansion and Functional Activity of Antigen-Specific Effector Memory T-Cells (TEM) While Co-Expression of IL-15 and IL-15 Rα on Antigen Presenting Cells Also Promotes Expansion of Central Memory T-Cells (TCM)

2017 - Engineering Converted Autologous Hematopoietic Stem Cells From Vascular Endothelial for Treatment of Hemoglobinopathies

206 - Synergism between CAR T Cells and a Personalized Tumor Vaccine in Hematological Malignances

207. Optimal Activation of Both CD28 and 4-1BB in CAR-Targeted T Cells Results in Enhanced Tumor Eradication

225. Activation Signals from CD19-CAR Permit NFAT-Controlled Inducible Expression of Transgenes in PBMCs

269. Integrated CD28 and 4-1BB Signals Strongly Potentiate CD8+ T Cell Mediated radication of Metastatic Prostate Cancer

274. One-Step Generation of Universal CAR T Cells

3152 – GENOMICS OF MULTIPLE MYELOMA DICTATES THE EXPRESSION OF CAR T-CELL TARGETS

317 BLOCKADE OF TGFβ ENHANCES EFFICACY OF GENETICALLY MODIFIED HUMAN T CELLS TARGETED AGAINST PROSTATE SPECIFIC MEMBRANE ANTIGEN

317 BLOCKADE OF TGFβ ENHANCES EFFICACY OF GENETICALLY MODIFIED HUMAN T CELLS TARGETED AGAINST PROSTATE SPECIFIC MEMBRANE ANTIGEN

343. Repair of the Sickle-Cell Disease Mutation in Human Stem Cells Using CRISPR/Cas9 and Single-Stranded Oligodeoxynucleotides

4-1BBL costimulation enables CD4 T cells expressing a CD28/zeta chimeric antigen receptor to eliminate aggressive leukemia. (P4338)

459. Evaluation of Miltenyi ExpAct and TransAct CD3/28 Beads for CAR-T Cell Manufacturing

475. Phase I Clinical Trial of Autologous CD19-Targeted 19-28z CAR T Cells in Adult Patients With Relapsed or Refractory B-ALL

512 Targeting HLA-E positive cancers with a novel NKG2A/C switch receptor

608: Neutral Endopeptidase Targeted to Prostate Cancer Cells Via Fusion with an Anti-Prostate Specific Membrane Antigen Monoclonal Antffiody

652. Analysis of the Genomic Stability of Herpes Simplex Virus Thymidine Kinase Variants in Retrovirally Transduced Lymphocytes

IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell–mediated rejection of systemic lymphoma in immunodeficient mice

763. Multimodality Imaging of Genetically Modified Lymphocytes In Vivo

Abstract 1150: CD70 HIT T cells overcome tumor antigen heterogeneity in renal cell carcinoma

Aktive Filter

Suchergebnisse filtern